Suppression of skin tumorigenesis in CD109-deficient mice-Reference-Cited by-同舟云学术

Suppression of skin tumorigenesis in CD109-deficient mice

Published:2016-10-14 Issue:50 Volume:7 Page:82836-82850
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Sunagawa Masaki¹²,Mii Shinji¹³,Enomoto Atsushi¹,Kato Takuya⁴,Murakumo Yoshiki⁵,Shiraki Yukihiro¹,Asai Naoya³,Asai Masato¹,Nagino Masato²,Takahashi Masahide¹³

Affiliation:

1. Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan

2. Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan

3. Division of Molecular Pathology, Center for Neurological Disease and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan

4. Tumour Cell Biology Laboratory, The Francis Crick Institute, Lincoln's Inn Fields Laboratories, London, United Kingdom

5. Department of Pathology, Kitasato University School of Medicine, Sagamihara, Japan

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significance of expression of CD109 in osteosarcoma and its involvement in tumor progression via BMP signaling;Pathology - Research and Practice;2023-05

2. Application of small extracellular vesicles in the diagnosis and prognosis of nasopharyngeal carcinoma;Frontiers in Cell and Developmental Biology;2023-03-10

3. Anti-Malignant Effect of Tensile Loading to Adherens Junctions in Cutaneous Squamous Cell Carcinoma Cells;Frontiers in Cell and Developmental Biology;2021-11-11

4. Serum CD109 levels reflect the node metastasis status in head and neck squamous cell carcinoma;Cancer Medicine;2021-02

5. Aptamer-based CRISPR/Cas12a assay for the ultrasensitive detection of extracellular vesicle proteins;Talanta;2021-01